In the space of about two months, Tandem announced continuous glucose monitor (CGM) integration with the latest-generation technology from Dexcom and Abbott, launched its Tandem Source diabetes management platform and began the rollout of its new Mobi miniature insulin pump.
Those milestones added to the January 2023 acquisition of AMF Medical, adding a differentiated patch pump to the Tandem portfolio.
“We certainly didn’t plan that from the outset, [to] do four back-to-back releases,” Gasser told Drug Delivery Business News. “Sometimes that’s how technology comes out along the way. It’s made for a busy, intense year.”
Tandem’s t:slim X2 has used Control IQ automated insulin delivery (AID) software for years. But the company’s newest offering highlights another diabetes care trend: miniaturization.
Those trends of automation and miniaturization help reduce cognitive burden for patients, Gasser said: “We can make it more wearable and more convenient.”
Get the full story at our sister site, Drug Delivery Business News.